What does Macquarie think Challenger shares are worth?

The company posted its Q1 update on Thursday.

| More on:
A group of people in an office celebrating.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Challenger reported a 4% increase in total life sales to $2.5 billion for the quarter. 
  • Challenger shares are 0.98% lower today at $9.07, yet have risen 45.2% over the year, with Macquarie maintaining an outperform rating and adjusting the price target to $9.30.
  • Macquarie sees a potential 2.5% upside, supported by reaffirmed FY26 earnings guidance, though earnings estimates were slightly reduced, with the stock trading at a ~13.6x forward P/E.

The Challenger Ltd (ASX: CGF) share price opened in the red on Friday morning. At the time of writing, the share price is 0.98% lower and changing hands at $9.07 a piece. 

Over the past month, Challenger's shares have risen 3.6% and they've surged 45.2% higher over the year.

Today's dip follows the annuities company's first-quarter update, released yesterday morning. 

It revealed that total life sales were up 4% during the quarter to $2.5 billion. Meanwhile, lifetime annuity sales were up 16% to $320 million during the quarter. 

Fixed term annuity sales grew strongly and were up 29% over the period, too, to $1.1 billion, and retail fixed term annuity sales fell 18% during the quarter. 

Over in Japan, its annuity sales were stable at $246 million for the period.

Management said it believes the company is tracking to its FY26 guidance. Therefore, it has reaffirmed its earnings per share guidance of between 66 cents and 72 cents per share. 

Macquarie Group Ltd (ASX: MQG) has sent a note to investors following Challenger's latest announcement, updating their stance on the shares.

What's ahead for Challenger shares? 

The broker has confirmed its outperform rating on Challenger shares. It has also lowered its target price to $9.30 per share, down from $9.60 in August. At the time of writing, this represents a potential upside of 2.5% for investors over the next 12 months.

"Valuation: We trim our 12-month target price by 3% to A$9.30, from A $9.60, based on a DCF/Gordon Growth methodology," the broker said in its note.

"Outperform. Buybacks and an additional Japanese distribution partnership are in our numbers."

The broker added that Challenger's FY26 guidance, normalised basic earnings per share of 66 to 72, was reaffirmed with group normalised net profit after tax of between $455 million and $495 million.

"Overall, the results were mixed with a decent showing in the annuities book offset by disappointing flows in the Funds Management (FM) division," it said.

Japanese sales represented ~15.0% of 1Q26, which represents normal 1Q seasonality for the group.

"Earnings changes: We lower earnings by 2.7% for FY26E, 4.5% for FY27E, and ~4% thereafter to reflect the quarterly flows update in both the annuities and Funds Management divisions," Macquarie said.

"CGF currently trades at a ~13.6x 12-month forward P/E on FactSet consensus, ~15% above the 3-yr average of ~11.8x. This translates to a ~30% discount vs the ASX100 (compared with the 3-year average discount of ~27%)."

Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group. The Motley Fool Australia has positions in and has recommended Macquarie Group. The Motley Fool Australia has recommended Challenger. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Financial Shares

Stethoscope with a piggy bank in the middle.
Financial Shares

NIB share price up 22% in 12 months, but could face short-term weakness. Here's what investors should know

NIB shares have risen strongly over the past year, but recent weakness suggests momentum may be easing.

Read more »

A woman wearing a lifebuoy ring reaches up for help as an arm comes down to rescue her.
Financial Shares

Goldman Sachs tips 19% upside for Suncorp shares…plus dividends!

Goldman Sachs expects Suncorp shares to outperform in 2026.

Read more »

a woman sits in comtemplation with superimposed images of piles of gold coins, graphs and star-like lights above her head as though she is thinking about investment options.
Blue Chip Shares

If I invest $15,000 in Macquarie shares, how much passive income will I receive in 2026?

Is Macquarie a great option for dividend income?

Read more »

Five candles on birthday cake.
Financial Shares

5 ASX financial shares to buy in 2026

Here are 5 ASX financial shares that the experts are backing for price growth this year.

Read more »

Australian dollar notes in the pocket of a man's jeans, symbolising dividends.
Financial Shares

Own AMP shares? Here are your key dates for the year

Full-year results are not far off.

Read more »

Two people in flying suits and helmets cruise in mid-air high above the earth with arms outstretched and the sun on the horizon.
Financial Shares

Can these high flying financials shares from last year do it again?

Is it too late to jump on board these soaring stocks?

Read more »

Person sitting on couch with computer on lap whilst flood waters rise around ankles
Financial Shares

Which ASX insurance stock to buy in 2026: QBE or Suncorp?

Most analysts see a better 2026, but risks remain.

Read more »

Australian dollar notes in the pocket of a man's jeans, symbolising dividends.
Financial Shares

This fund has just declared a special dividend after "record outperformance"

The investment team at this fund says there's still plenty left in the tank after boosting dividend payouts substantially.

Read more »